News

The IND application seeks permission to conduct clinical trial in human non-patient volunteers. Prior to submitting the IND, the company has conducted meeting with the FDA and the

In the trial, inecalcitol was 11 times potent than a naturally active metabolite of vitamin D, calcitriol in suppressing the growth in-vitro of the human hormone-dependent prostate cancer

Gilead has also entered into a licensing agreement with the Medicines Patent Pool Foundation. The agreement allows the Indian firms to market the generic Elvitegravir, Cobicistat and Quad.

Fondaparinux Sodium Injection is the generic version of GlaxoSmithKline’s (GSK) Arixtra which is indicated as a treatment for acute deep vein thrombosis when administered in conjunction with warfarin

Ursodiol is a generic version of Axcan’s Urso 250mg and Urso Forte tablets. The final approval has been given for Glenmark’s abbreviated new drug application (ANDA) for generic

Under the agreement, MANF-based therapeutic will be developed using Generex’s RapidMist technology in conjunction with oral-insulin spray technology Oral-lyn. Amarantus chief scientific officer John Commissiong said MANF’s profile

Perifosine, which is an oral anticancer drug that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, has been granted orphan drug status by the US Food and

As per the terms of the deal, Orion will license the Chinese marketing rights of these two drugs to Eisai. Eisai will distribute the drugs through its Chinese

Roche’s NimbleGen SeqCap EZ Library solution will be used for Caliper’s Sciclone NGS Workstation. The transaction aims to simplify targeted resequencing workflows by developing automated methods for sequencing